(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

IMMUNOSCORE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

IMMUNOSCORE

ST13

US500000079124758

Class

1, 5, 9, 10, 42, 44

Filing

79124758

Registration

4513051

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

63

Latest update

01/17/2026

Trademark type

Word

Nice classes

1, 5, 9, 10, 42, 44

Filing date

08/10/2012

Registration date

04/15/2014

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/20/2024

Last transaction

01/17/2026

Responsible office

United States Patent and Trademark Office

Status code

708

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

PARIS, FR

Examiner

AGOSTO,GISELLE MARIE

Current location

Historical data usage

Holders and representatives

Holders

INSERM (Institut National de la Santé etet de la Recherche Médicale)
INSERM; (Institut National de la Santé; et de la Recherche Médicale)

Representatives

Douglas R. Wolf Wolf, Greenfield & Sacks, P.C.

Technical classification

Nice Classes

Class 1Class 5Class 9Class 10Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Cultures of microorganisms other than for medical and veterinary use; diagnostic preparations of microorganisms for scientific purposesfor diagnostic purposesfor laboratory or research use; chemical reagents other than for medical or veterinary use; biomolecule marking kits comprising reagents for scientific research; reagents for scientific applications; and antibodies for scientific use

Class 5

Chemical reagents for medical or veterinary use; clinical medical reagents; cultures of microorganisms for medical or veterinary use; diagnostic preparations for medical use; cultures of microorganisms for medical or veterinary use; chemicalpharmaceutical and biological preparations for the diagnosis of cancer and for the evaluation of a patient's reaction time to cancer treatments; and antibodies for the diagnosis of cancer and for the evaluation of a patient's reaction time to cancer treatments

Class 9

Microscopes; scanners; computer programs recorded on software and data-computing software for the diagnosis of cancer and the evaluation of a patient's reaction time to cancer treatments; and image analysis software

Class 10

Medical and diagnostic apparatus and instruments for the diagnosis of cancer and the evaluation of a patient's reaction time to cancer treatments; microscopes for medical use; high-resolution scanners for use in scientific and medical research; and tissue sample preparation devices for medical diagnostic usesdetecting abnormal cancer cells

Class 42

Research and development of pharmaceutical products; software design; software design and development; designmaintenance and updating of software ; software consultancy

Class 44

Medical assistance; hospital services; health care; performing diagnosis of diseasescancerproviding information in the field of cancer diagnosis

Publications

History of USPTO decisions and trademark events.

63 publications found

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

01/16/2026

XXCR

GENERIC MADRID TRANSACTION CREATED

01/16/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

08/14/2025

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

07/20/2025

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

11/20/2024

C75P

REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.

11/20/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/18/2024

ES75

TEAS SECTION 71 & 15 RECEIVED

04/05/2024

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

04/15/2023

RNWL

INTERNATIONAL REGISTRATION RENEWED

08/25/2022

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

06/13/2021

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

03/19/2021

XXCR

GENERIC MADRID TRANSACTION CREATED

03/19/2021

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

03/14/2021

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

07/14/2020

71AG

REGISTERED-SEC.71 ACCEPTED

07/14/2020

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

06/25/2020

PR71

POST REGISTRATION ACTION MAILED - SEC.71

06/22/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/30/2020

ES71

TEAS SECTION 71 RECEIVED

03/16/2020

NREP

NEW REPRESENTATIVE AT IB RECEIVED

12/12/2019

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

04/15/2019

NREP

NEW REPRESENTATIVE AT IB RECEIVED

01/24/2019

NREP

NEW REPRESENTATIVE AT IB RECEIVED

12/14/2018

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

09/11/2014

FICS

FINAL DISPOSITION NOTICE SENT TO IB

08/25/2014

FIMP

FINAL DISPOSITION PROCESSED

08/25/2014

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

07/15/2014

R.PR

REGISTERED-PRINCIPAL REGISTER

04/15/2014

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/28/2014

PUBO

PUBLISHED FOR OPPOSITION

01/28/2014

GPNX

NOTIFICATION PROCESSED BY IB

01/25/2014

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/08/2014

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

01/08/2014

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/08/2014

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

12/20/2013

ALIE

ASSIGNED TO LIE

12/19/2013

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/16/2013

XAEC

EXAMINER'S AMENDMENT ENTERED

12/16/2013

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

12/16/2013

GNEA

EXAMINERS AMENDMENT E-MAILED

12/16/2013

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/16/2013

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/16/2013

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

11/13/2013

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/13/2013

GNRT

NON-FINAL ACTION E-MAILED

09/13/2013

CNRT

NON-FINAL ACTION WRITTEN

09/13/2013

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/25/2013

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/25/2013

ALIE

ASSIGNED TO LIE

08/22/2013

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/19/2013

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/16/2013

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/16/2013

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/18/2013

RFNT

REFUSAL PROCESSED BY IB

03/11/2013

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

02/21/2013

RFRR

REFUSAL PROCESSED BY MPU

02/21/2013

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

02/21/2013

CNRT

NON-FINAL ACTION WRITTEN

02/20/2013

MAFR

APPLICATION FILING RECEIPT MAILED

02/19/2013

DOCK

ASSIGNED TO EXAMINER

02/13/2013

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/13/2013

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

02/09/2013

Continuous trademark protection

Get notified about every new filing that threatens IMMUNOSCORE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.